EXPE : Summary for Expedia, Inc. - Yahoo Finance

U.S. Markets closed

Expedia, Inc. (EXPE)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
118.81+0.80 (+0.68%)
At close: 4:00PM EST
People also watch
TRIPPCLNEXPDDISCAFISV
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close118.01
Open118.01
Bid118.51 x 300
Ask119.27 x 300
Day's Range117.81 - 120.44
52 Week Range88.40 - 133.55
Volume2,333,282
Avg. Volume2,335,358
Market Cap17.83B
Beta1.31
PE Ratio (TTM)18.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.04 (0.88%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopedia15 hours ago

    Why These Big Tech Stocks Are Poised to Rise

    Tech stocks such as Facebook, Amazon and Alphabet are likely to rise in 2017.

  • Barrons.com3 days ago

    [$$] Credit Suisse Likes Expedia's Mash-Up of Brands

    Abbott Laboratories • ABT-NYSE Overweight • Price $40.74 on Jan. 9 by Barclays With the Jan. 4 close of Abbott’s acquisition of medical-device maker St. Jude Medical (STJ), we are updating our model to include both that purchase and recent divestitures (including Abbott medical optics and vascular units). For 2018, our EPS estimate has increased three cents, to $2.80, to reflect approximately 10% organic EPS growth and additional accretion from St. Jude of some 10 cents in earnings. In our view, Abbott shares have been dislocated by the noise around these deals and near deals, and we see this as a unique opportunity to buy a quality asset at a discount.

  • Priceline, Expedia Outperform, TripAdvisor Neutral In New Coverage
    Investor's Business Daily5 days ago

    Priceline, Expedia Outperform, TripAdvisor Neutral In New Coverage

    Online travel remains a competitive, fragmented field where Priceline and Expedia continue to do well, says new analyst coverage at Credit Suisse.